Navigation Links
Maastricht University Medical Centre Advances Cranial Implant Technology with PEEK-OPTIMA
Date:6/2/2010

Maastricht University Medical Centre (MUMC+) has developed a novel cranio-maxillofacial implant technology that uses an advanced polymer biomaterial, PEEK-OPTIMA®, from Invibio Biomaterial Solutions. The polymer derived Patient Specific Implant (PSI) technology extends the range of patient/surgeon benefits beyond those of medical-grade titanium, the traditional biomaterial used for cranio-maxillofacial PSIs.

(PRWEB) June 2, 2010 -- Maastricht University Medical Centre (MUMC+) has developed a novel cranio-maxillofacial implant technology that uses an advanced polymer biomaterial, PEEK-OPTIMA®, from Invibio Biomaterial Solutions, to extend benefits to patients with severe malformation and defects of the skull and facial region. Patient-specific cranial implants are most commonly used to treat skull defects resulting from trauma, tumors and aneurysms.

The PEEK-OPTIMA® derived Patient Specific Implant (PSI) technology extends the range of patient/surgeon benefits beyond those of medical-grade titanium, the traditional biomaterial used for cranio-maxillofacial PSIs. The MUMC+ process uses CAD software to design the PSI to the individual cranio-maxillofacial contours of the patient. The customized implants are produced on-site, using a high speed milling fabrication process.

According to Maikel Beerens (B.Sc. in Medical Engineering), who initially designed and now markets IDEE’s (Instrument Development Engineering & Evaluation) patient specific implants (PSI), PEEK-OPTIMA’s material characteristics and performance properties provide real and valuable surgeon/patient benefits that include:

 
  • Ideal biological properties very comparable to bone;
  • No stress shielding;
  • No conductibility of temperature;
  • Separation of PEEK from surrounding bone, which ensures the initial position of the implant
  • Proven biocompatibility and biostability,
  • Natural radiolucency and compatibility with medical imaging to monitor site healing

“The patient’s own removed bone segments are always the first choice for implantation. However, unfortunately only a few of those re-implantations succeed, leaving the patient with a defect. To reconstruct this defect in the best way possible the surgeon uses a patient specific implant.

Although the use of PEEK is relatively new in the case of cranial implants, Invibio’s PEEK-OPTIMA® is proven with over 10 years of history in a wide variety of different regulatory approved devices. Their verified biocompatibility and biostability is crucial for surgeons when choosing materials”, commented Peter Kessler (chair professor, Department of Cranio-Maxillofacial Surgery, MUMC+).

The novel cranio-maxillofacial implant technology was co-developed by Maastricht University Medical Centre’s engineering department IDEE (Instrument Development Engineering & Evaluation), the Department of Cranio-Maxillofacial Surgery and Maastricht Instruments (MI).

About Invibio:
Invibio® is a global leader providing high performance biomaterials, advanced technical research and consultative solutions to medical device manufacturers across a wide range of markets. The company provides medical device manufacturers with PEEK-OPTIMA® polymer and compounds, MOTIS™ polymer, ENDOLIGN® composite and PEEK-CLASSIX™ polymer for the development of long- and short-term implantable medical devices.

For more information, please contact Invibio at: 866 468 4246 or +484 342 6004 (U.S.), +44 (0) 1253 898000 (U.K.), +852 2366 4448 (Asia Pacific) or online at www.invibio.com.

About IDEE:
IDEE (Instrument Development Engineering & Evaluation) is the engineering department of Maastricht University (UM). It provides services to the Faculty of Health, Medicine & Life Sciences (FHML) as well as the university hospital Maastricht (azM) together named MUMC+. IDEE develops innovative and unique medical devices to support academic, medical and industrial R&D focused on Life Sciences.

About Maastricht Instruments:
Maastricht Instruments BV (MI) is a high-tech solution provider within the medical field and life sciences as well as industrial related R&D. Located within the premises of the MUMC+ and working very closely with IDEE and the local medical researchers, MI has access to in-depth medical knowledge and experience. Based upon the medical know-how, combined with excellent competences of mechanical, electronic and software development, MI is able to realize creative proof of concept equipment & services and innovative “first of a kind” prototypes. Typical customers are researchers from universities, (academic) hospitals, medical centers, care institutes and industrial R&D institutes worldwide.
For more information, please contact MI at: Tel +31 (0) 43 3881371 or online at www.maastrichtinstruments.com, in the Patient Specific Implants section.

About the Maastricht University Medical Centre (MUMC+):
The Department of Cranio-Maxillofacial Surgery of the Maastricht University Medical Centre is specialized in cranio-maxillofacial reconstructions. The range of reconstructive procedures comprises also the reconstruction of large skull bone defects of various origins. Customized implants of various materials can be applied. The experience and close cooperation with the Department of Neurosurgery renders excellent functional and aesthetic results. The cooperation with IDEE guarantees safety, reliability and the of use state-of-the-art technologies. For more information visit MUMC+ at www.azm.nl.

###

Read the full story at http://www.prweb.com/releases/2010/06/prweb4074614.htm.


'/>"/>
Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved  

Related medicine news :

1. University of Minnesota, Mayo Clinic sign research pact with Karolinska
2. New research at the University of Leicester links shoplifting to your personality
3. University of Colorado Hospital Moving Forward with $400 Million Expansion
4. University Hospitals Neurological Institute earns Neuroscience Center of Excellence designation
5. Center for the Study of Aging established at University of Denver
6. University of Washington launches project to discover fundamentals of early learning
7. University of Washington Institute for Learning & Brain Sciences Launches Developing Mind Project
8. Water Enabled Technologies of Utah Signs MOU with Clemson University, South Carolina, for Water Desalination
9. Chicago Trial Attorney Inducted as Loyola University Chicago School of Law's First Cooney & Conway Chair in Advocacy
10. Life sciences research grants awarded through Inova Health System and George Mason University
11. FightSMA Awards $250,000 Grant to Gene Researcher at The Ohio State University
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Maastricht University Medical Centre Advances Cranial Implant Technology with PEEK-OPTIMA 
(Date:2/23/2017)... ... 23, 2017 , ... On April 13, 2017, The ... “Doping in Sport: How the Culture Might Change,” in conjunction with Pepperdine ... will be held at Pepperdine University in Malibu, California. , Sir Philip Craven, ...
(Date:2/23/2017)... ... February 23, 2017 , ... ERT, ... trials, today announced that Premier Research, a leading clinical development service provider, has ... are becoming increasingly complex, due in part to an array of circumstances including ...
(Date:2/23/2017)... ... February 23, 2017 , ... The Center ... Rhode Island Consortium for Autism Research and Treatment (RI-CART) and Cinemaworld to present ... spectrum disorder (ASD) to see films in an environment that accommodates their unique ...
(Date:2/23/2017)... ... February 23, 2017 , ... Top cosmetic and periodontal dentist ... today with a new Indiegogo campaign . Individuals are now able to contribute ... Los Angeles area, either as a participating patient or through an Indiegogo donation. The ...
(Date:2/23/2017)... ... February 23, 2017 , ... Thomas Vas-Don suffered from ... regime, the author was able to successfully recover. In “ Origin & Insertion Charts ... various sources on the principals of massage, anatomy , trigger points and ...
Breaking Medicine News(10 mins):
(Date:2/23/2017)... YORK , Feb. 23, 2017  Genesis Healthcare ... Company. The announcement was made by Bill Monast ... David Hartley and Nathan Feltman , executives ... Genesis Healthcare Services, LLC. This acquisition ... largest provider of technology enabled durable medical equipment (DME) ...
(Date:2/23/2017)... Feb. 23, 2017 Nevro Corp. (NYSE: NVRO), a ... for the treatment of chronic pain, today reported financial results ... 2016. 2016 Accomplishment & Highlights: ... 2016, an increase of 228% as reported, over the prior ... an increase of 612% over the prior year ...
(Date:2/23/2017)... , Feb. 23, 2017 Research and Markets ... and Strategies - 2016" report to their offering. ... The latest research Fibromyalgia ... and benchmarks in the global Fibromyalgia market. The research ... key drugs marketed for Fibromyalgia and their clinical attributes? How are ...
Breaking Medicine Technology: